semaglutide bowel obstruction lawyer in michigan glp-1 gastrointestinal law office Patients claim blindness, injuries from GLP-1 drugs semaglutide gastric intestinal obstruction attorney

Vos MB, Welsh J

Some companies were selling products claiming to contain semaglutide at standard doses, but which contained minimal to no active drug

Cell Press American Journal of Physiology, Gastrointestinal and Liver Physiology, 2011

[3] [1] Ozempic is also not indicated for type 1 diabetes or the treatment of diabetic ketoacidosis

Published in Diabetologia (Blher and colleagues, NCT04153929), this Phase 2 trial randomized 413 adults with type 2 diabetes on background metformin to survodutide across several once-weekly or twice-weekly dose groups, to placebo, or to open-label semaglutide up to 1.0 mg once weekly